UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The systemic treatment of recurrent ovarian cancer revisited

Annals of oncology, 2021-06, Vol.32 (6), p.710-725

2021

Volltextzugriff (PDF)

ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease

Annals of oncology, 2019-05, Vol.30 (5), p.672-705

2019

Volltextzugriff (PDF)

ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease

International journal of gynecological cancer, 2019-05, Vol.29 (4), p.728-760

2019

Volltextzugriff (PDF)

Ectopic retroviral expression of LMO2, but not IL2Rγ, blocks human T-cell development from CD34 + cells : implications for leukemogenesis in gene therapy

Leukemia, 2007-04, Vol.21 (4), p.754-763

2007

Volltextzugriff (PDF)

The E3 ubiquitin ligase complex component COP1 regulates PEA3 group member stability and transcriptional activity

Oncogene, 2010-03, Vol.29 (12), p.1810-1820

2010

Volltextzugriff (PDF)

Assessment of protein biomarkers for preoperative differential diagnosis between benign and malignant ovarian tumors

Gynecologic oncology, 2020-12, Vol.159 (3), p.811-819

2020

Volltextzugriff (PDF)

Orientation of Preclinical Research in Ovarian Cancer

International journal of gynecological cancer, 2017-10, Vol.27 (8), p.1579-1586

2017

Volltextzugriff (PDF)

Peripherally-driven myeloid NFkB and IFN/ISG responses predict malignancy risk, survival, and immunotherapy regime in ovarian cancer

Journal for immunotherapy of cancer, 2021-11, Vol.9 (11), p.e003609

2021

Volltextzugriff (PDF)

The Use of Toll-like Receptor 4 Agonist to Reshape the Immune Signature in Ovarian Cancer

Anticancer research, 2016-11, Vol.36 (11), p.5781-5792

2016

Volltextzugriff (PDF)

In Vitro Generation of Murine Dendritic Cells for Cancer Immunotherapy: An Optimized Protocol

Anticancer research, 2016-11, Vol.36 (11), p.5793-5801

2016

Volltextzugriff (PDF)

Regulation of the Ets-1 transcription factor by sumoylation and ubiquitinylation

Oncogene, 2007-01, Vol.26 (3), p.395-406

2007

Volltextzugriff (PDF)

Expression of the PEA3 group of ETS‐related transcription factors in human breast‐cancer cells

International journal of cancer, 1997-03, Vol.70 (5), p.590-597

1997

Volltextzugriff (PDF)

The 26S proteasome system degrades the ERM transcription factor and regulates its transcription-enhancing activity

Oncogene, 2007-01, Vol.26 (3), p.415-424

2007

Volltextzugriff (PDF)

Molecular characterization of the zebrafish PEA3 ETS-domain transcription factor

Oncogene, 1998-07, Vol.17 (1), p.93-104

1998

Volltextzugriff (PDF)

HLA-A0201-restricted CEA-derived peptide CAP1 is not a suitable target for T-cell-based immunotherapy

Journal of immunotherapy, 2010-05, Vol.33 (4), p.402-413

2010

Volltextzugriff (PDF)

Allelic imbalance of the TGFβR1 is not a major contributor to the genetic predisposition to colorectal cancer

British journal of cancer, 2011-04, Vol.104 (9), p.1517-1518

2011

Volltextzugriff (PDF)

Characterization of the human and mouse ETV1/ER81 transcription factor genes : role of the two alternatively spliced isoforms in the human

Oncogene, 1999-11, Vol.18 (46), p.6278-6286

1999

Volltextzugriff (PDF)

Molecular cloning and characterization of human ERM, a new member of the Ets family closely related to mouse PEA3 and ER81 transcription factors

Oncogene, 1994-05, Vol.9 (5), p.1397-1406

1994

Volltextzugriff (PDF)

The ETS-related transcription factor ERM is a nuclear target of signaling cascades involving MAPK and PKA

Oncogene, 1996-10, Vol.13 (8), p.1745-1754

1996

Volltextzugriff (PDF)

Whole bladder wall photodynamic therapy of transitional cell carcinoma rat bladder tumors using intravesically administered hypericin

International journal of cancer, 2003-11, Vol.107 (3), p.460-467

2003

Volltextzugriff (PDF)

Molecular characterization of the ets-related human transcription factor ER81

Oncogene, 1995-08, Vol.11 (4), p.771-779

1995

Volltextzugriff (PDF)

Biodistribution of hypericin in orthotopic transitional cell carcinoma bladder tumors: Implication for whole bladder wall photodynamic therapy

International journal of cancer, 2002-01, Vol.97 (2), p.253-260

2002

Volltextzugriff (PDF)

Diagnostic Nuclear Medicine

2nd Revised Edition, 2005

Volltextzugriff (PDF)

Head and Neck Cancer Imaging

Hermans, Robert

1. Aufl., 2006

Volltextzugriff (PDF)

Two functionally distinct domains responsible for transactivation by the Ets family member ERM

Oncogene, 1996-03, Vol.12 (6), p.1325-1336

1996

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(33)
Bücher
(5)

Sprache

Englisch
(38)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The systemic treatment of recurrent ovarian cancer revisited

ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease

ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease

Ectopic retroviral expression of LMO2, but not IL2Rγ, blocks human T-cell development from CD34 + cells : implications for leukemogenesis in gene therapy

The E3 ubiquitin ligase complex component COP1 regulates PEA3 group member stability and transcriptional activity

Assessment of protein biomarkers for preoperative differential diagnosis between benign and malignant ovarian tumors

Orientation of Preclinical Research in Ovarian Cancer

Peripherally-driven myeloid NFkB and IFN/ISG responses predict malignancy risk, survival, and immunotherapy regime in ovarian cancer

The Use of Toll-like Receptor 4 Agonist to Reshape the Immune Signature in Ovarian Cancer

In Vitro Generation of Murine Dendritic Cells for Cancer Immunotherapy: An Optimized Protocol

Regulation of the Ets-1 transcription factor by sumoylation and ubiquitinylation

Expression of the PEA3 group of ETS‐related transcription factors in human breast‐cancer cells

The 26S proteasome system degrades the ERM transcription factor and regulates its transcription-enhancing activity

Molecular characterization of the zebrafish PEA3 ETS-domain transcription factor

HLA-A0201-restricted CEA-derived peptide CAP1 is not a suitable target for T-cell-based immunotherapy

Allelic imbalance of the TGFβR1 is not a major contributor to the genetic predisposition to colorectal cancer

Characterization of the human and mouse ETV1/ER81 transcription factor genes : role of the two alternatively spliced isoforms in the human

Molecular cloning and characterization of human ERM, a new member of the Ets family closely related to mouse PEA3 and ER81 transcription factors

The ETS-related transcription factor ERM is a nuclear target of signaling cascades involving MAPK and PKA

Whole bladder wall photodynamic therapy of transitional cell carcinoma rat bladder tumors using intravesically administered hypericin

Molecular characterization of the ets-related human transcription factor ER81

Biodistribution of hypericin in orthotopic transitional cell carcinoma bladder tumors: Implication for whole bladder wall photodynamic therapy

Diagnostic Nuclear Medicine

Head and Neck Cancer Imaging

Two functionally distinct domains responsible for transactivation by the Ets family member ERM

Aktive Filter

Suchergebnisse filtern